DEPARTMENTS: Pharmacology Consult

Another Outcome of the COVID-19 Pandemic: The Possible Repurposing of Selective Serotonin Reuptake Inhibitors

O'Malley, Patricia Anne PhD, APRN-CNS

Author Affiliation: Nurse Researcher, Center of Nursing Excellence, Premier Health–Miami Valley Hospital, Dayton, Ohio.

The author reports no conflicts of interest.

Correspondence: Patricia Anne O'Malley, PhD, APRN-CNS, Center of Nursing Excellence, Premier Health–Miami Valley Hospital, 1 Wyoming St, Dayton, OH 45409 ([email protected]; [email protected]).

Clinical Nurse Specialist 36(5):p 241-243, 9/10 2022. | DOI: 10.1097/NUR.0000000000000696

Buy
CME Test

Full Text Access for Subscribers:

Individual Subscribers

Institutional Users

Access through Ovid^®

Not a Subscriber?

Buy

Request Permissions

You can read the full text of this article if you:

Access through Ovid

Secondary Logo

Journal Logo

Another Outcome of the COVID-19 Pandemic: The Possible Repurposing of Selective Serotonin Reuptake Inhibitors

Full Text Access for Subscribers:

Institutional Users

Not a Subscriber?

Article Level Metrics

Related Links

Related Videos

Readers Of this Article Also Read

Another Outcome of the COVID-19 Pandemic: The Possible Repurposing of Selective Serotonin Reuptake Inhibitors : Clinical Nurse Specialist

Full Text Access for Subscribers:

Individual Subscribers

Institutional Users

Not a Subscriber?